(Refers to editorial comment made by Jonathan Bergman, and Mark S. Litwin, in Urology, available online 14th April 2015.)

Abstract

We appreciate the comments regarding our article. Although the need to measure outcome from the patients' perspective is being increasingly recognized across the surgical disciplines, it is important that those collecting such data use suitable instruments and understand how one can judge the appropriateness of one instrument over another. With localized prostate cancer having such a low mortality rate, it is understandable that morbidity and the assessment of quality of life measured from the patients' perspective is an important outcome measure in this patient group.